1-hexylindolactam-V10

a protein kinase C activator; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Reperfusion Injury 01/10/2008 - "We developed 1-hexylindolactam-V10 ( 5) as a selective activator for novel PKC isozymes that play important roles in various cellular processes related to tumor promotion, ischemia--reperfusion injury in the heart, and Alzheimer's disease. "
2.	Neoplasms (Cancer) 01/10/2008 - "We developed 1-hexylindolactam-V10 ( 5) as a selective activator for novel PKC isozymes that play important roles in various cellular processes related to tumor promotion, ischemia--reperfusion injury in the heart, and Alzheimer's disease. "
3.	Alzheimer Disease (Alzheimer's Disease) 01/10/2008 - "We developed 1-hexylindolactam-V10 ( 5) as a selective activator for novel PKC isozymes that play important roles in various cellular processes related to tumor promotion, ischemia--reperfusion injury in the heart, and Alzheimer's disease. "

1.	Isoenzymes